Time course of pathologic changes in kidney allografts of positive crossmatch HLA-incompatible transplant recipients

Transplantation. 2014 Feb 27;97(4):440-5. doi: 10.1097/01.TP.0000437177.40551.f4.


Background: Recipients of incompatible allografts are at increased risk of graft loss. We hypothesized that analysis of sequential biopsies from these grafts could define progression of graft lesions and identify features predictive of progression.

Methods: We studied the time course of histologic injury in 745 kidney graft biopsies from 129 patients transplanted with a positive crossmatch human leukocyte antigen-incompatible kidney between 2000 and 2010 (follow-up of 1-9 years).

Results: Graft survival was 98% at 1 year and 80% at 5 years after transplantation. Throughout follow-up, 70% of patients experienced rejection, with 52% showing subclinical rejection in the first year. Cell-mediated rejection was more frequent than antibody-mediated rejection throughout follow-up. Transplant glomerulopathy (TxGN; cg≥1) developed in 47% of patients over the period of the study, as early as 3 months in a few patients. TxGN was preceded by glomerulitis in more than 90% of cases, with a median time interval of 12 months. Glomerulitis and detectable posttransplantation donor-specific antibodies were risk factors for TxGN (P<0.0001 and P<0.05). C4d-negative antibody-mediated rejection manifesting as capillaritis (g≥1 and ptc≥1) with detectable donor-specific antibodies was observed in some recipients (<20%). There was progressively higher average tubulointerstitial scarring (ci+ct) from 3 to 6 to 12 months (P<0.001).

Conclusions: Despite good graft survival, a significant incidence of biopsy-proven rejection occurred in this subset of closely monitored human leukocyte antigen-incompatible recipients throughout follow-up. Microcirculation inflammation, particularly glomerulitis, irrespective of C4d, is associated with a high risk of development of TxGN at 1 year.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Aged
  • Antibodies / chemistry
  • Biopsy
  • Complement C4b / immunology
  • Disease Progression
  • Female
  • Follow-Up Studies
  • Graft Survival / immunology
  • HLA Antigens / immunology*
  • Histocompatibility Testing
  • Humans
  • Immunosuppression / methods
  • Inflammation
  • Kidney / immunology*
  • Kidney / pathology
  • Kidney Diseases / immunology
  • Kidney Diseases / therapy
  • Kidney Transplantation / adverse effects*
  • Kidney Transplantation / methods*
  • Male
  • Microcirculation
  • Middle Aged
  • Peptide Fragments / immunology
  • Renal Insufficiency / immunology*
  • Risk Factors
  • Time Factors
  • Tissue Donors
  • Young Adult


  • Antibodies
  • HLA Antigens
  • Peptide Fragments
  • Complement C4b
  • complement C4d